Journal of Agricultural and Food Chemistry
Article
Sodium phosphate was used as the calcium-binding buffer, which
could react with calcium ion and peptide, separately, and show
obviously different reactions. Calcium ion could combine with
phosphate to form calcium phosphate precipitation, while peptide
could take calcium ion from precipitation. As a result, peptide−Ca
chelate was a water-soluble substance, and a soluble calcium content in
the supernatant represented the calcium content associated with the
peptide.16 The calcium contents in the supernatant were determined
using a colorimetric method with ortho-cresolphthalein complexone
reagent.17 The absorbance at 570 nm was determined after adding the
working solution to the sample. The experiments were performed in
triplicate, and values were expressed as the mean standard deviation
(SD).
Characterization of the Purified Calcium-Binding Peptide.
Formation of the Peptide−Calcium Chelate. Peptide−calcium
chelate was the chelating component of the reaction between
dipeptide Gly-Tyr and calcium ion. The calcium-binding chelate was
prepared by adding 5 mL of 1% (w/v) CaCl2 into 20 mL of 2.5% (w/
v) calcium-binding peptide solution. The reaction was placed in a
controlled water bath with constant agitation (100 rpm) at 37 °C for 2
h after the pH of the solution was adjusted to 7.0 by the addition of 0.1
M NaOH. Then, the mixture was added with absolute ethanol (9
times of solution volume) to remove free calcium and centrifuged at
10000g for 10 min, and the precipitates was lyophilized for analysis.
Ultraviolet (UV) Absorption Spectroscopy Assay. The UV spectra
of the calcium-binding peptide and peptide−calcium chelate were
recorded over the wavelength range from 190 to 400 nm by a UV−vis
spectrophotometer (UV-2600, UNICO Instrument Co., Ltd.,
Shanghai, China) as the method described by Chen et al.18 The
calcium-binding peptide of 0.2 mg/mL was prepared. The peptide−
calcium chelate was prepared by adding 0, 2, 4, 6, 8, and 10 μM CaCl2
to 0.2 mg/mL calcium-binding peptide solution, separately. The mixed
solution reacted at room temperature for 30 min.
Fluorescence Spectra Analysis. Fluorescence spectra were
measured to monitor conformational changes in the peptide induced
by calcium chelation using the F-4600 fluorescence spectrophotometer
(Hitachi Co., Japan). The excitation wavelength was 280 nm, and
emission wavelengths between 290 and 360 nm were recorded.
Fourier Transform Infrared Spectroscopy (FTIR) Measurement. A
total of 1 mg of calcium-binding peptide powder or peptide−calcium
chelate was ground evenly with 100 mg of dry KBr under infrared light
to the size below 2.5 μm. Then, the transparent KBr piece was made at
60 MPa. To examine whether the variation in pellet thickness causes
significant interference in the measured spectra, three different pellets
were prepared from the same sample and their FTIR spectra were
compared. The average of these three spectra was then used for
analysis. The FTIR spectra were recorded using an infrared
spectrophotometer (360 Intelligent, Thermo Nicolet Co., Waltham,
MA) over a wavenumber region between 4000 and 400 cm−1 at a
resolution of 4 cm−1, and the sample spectra were background-
subtracted using a spectrum collected in the absence of a peptide−
calcium chelate sample. Therefore, the physical variation in the FTIR
spectra caused by the KBr technique had been removed prior to the
FTIR spectra analysis. A total of 64 scans were recorded per sample in
the FTIR spectra, and the peak signals in the spectra were analyzed
using OMNIC 8.2 software (Thermo Nicolet Co., Madison, WI).
1H Nuclear Magnetic Resonance (NMR) Spectroscopy Assay. The
peptide−calcium chelate and calcium-binding peptide (0.5 mg) were
dissolved in 500 μL of deionized water, separately. A total of 50 μL of
deuterium oxide (D2O) was added after the pH of the solution was
adjusted to 6.5. The samples were transferred into 5 mm NMR tubes
and subjected to NMR analysis with a Bruker Avance III spectrometer
(Bruker Biospin, Rheinstetten, Germany).
activity of calcium-binding peptides may be used as one kind of
food additive that prevents bone disorders.
MATERIALS AND METHODS
■
Materials. Whey protein (WPC80, containing 80.5% protein) was
kindly provided by Hilmar Corporation (Batch 20111107, Hilmar,
CA). The commercial proteases, Flavourzyme (EC. 3.4.11.1, 2 × 106
units/g) and Protamex (EC. 3.4.24.28, 1.5 × 106 units/g), were
purchased from Novo (Novozymes, Denmark). Toyopearl DEAE-
650M and Sephadex G-25 were offered by Amersham Pharmacia
(Amersham Pharmacia Co., Uppsala, Sweden). All of the other
chemicals and solvents were of analytical grade.
Hydrolysis of Whey Protein. A total of 5% (w/v) whey protein
solution was denatured in 80 °C for 20 min, and the pH was adjusted
to 7.0. The sample was hydrolyzed using Flavourzyme and Protamex
(2:1, w/w) with a substrate/enzyme ratio of 25:1 (w/w) at 49 °C for 7
h. Hydrolysate was heated at boiling water for 10 min to inactive the
enzyme and cooled to room temperature. The mixture was
subsequently centrifuged at 16000g for 20 min, and then the
supernatant named whey protein hydrolysate (WPH) was lyophilized
and stored at −20 °C for subsequent investigation.
Purification and Identification of Calcium-Binding Peptide.
Ion-Exchange Chromatography on Diethylaminoethyl (DEAE). The
peptide that could bind with calcium and form peptide−calcium
chelate was defined as the calcium-binding peptide. The slurry of
Toyopearl DEAE-650M was packed in a column (20 × 2.5 cm) and
then equilibrated at 5 column volume (CV) of 20 mM Tris-HCl buffer
(pH 9.0) as the equilibrating buffer. Afterward, 100 mg of the
lyophilized hydrolysates that had been through 0.45 μm filter film was
dissolved in 10 mL of the same buffer (pH 9.0) and loaded on the
column. Then, after washing with the equilibrating buffer, the collected
peak was labeled as the non-absorbed fraction. The bond peptides
were eluted by a gradient elution with the same buffer containing 0−
0.5 M NaCl. The flow rate was 0.5 mL/min; fraction volume was 5
mL/tube; elution was monitored at 214 nm; all peaks were collected;
and calcium-binding capacities of the fractions were determined.
Gel Filtration on Sephadex G-25. The fraction with the highest
calcium-binding capacity was pooled and lyophilized; 200 mg of the
sample was dissolved in 5 mL of deionized water and loaded onto a
Sephadex G-25 column (100 × 2.0 cm), which had previously been
equilibrated with deionized water, and then eluted with deionized
water at a flow rate of 0.3 mL/min. The eluate was monitored by
measuring the absorbance at 214 nm. After calcium-binding capacity
was determined, the fraction with the highest activity was pooled and
lyophilized.
High-Performance Liquid Chromatography (HPLC) on C18. The
lyophilized sample collected from G-25 was dissolved in distilled water
approximately equivalent to 30 mg/mL and purified by semi-
preparative reversed-phase high-performance liquid chromatography
(RP-HPLC) on C18 reversed silica gel chromatography (Gemini 5 μm
C18, 250 × 10 mm, Phenomenex, Inc., Torrance, CA). Elution was
performed on solution A [0.05% trifluoroacetic acid (TFA) in water]
and solution B (0.05% TFA in acetonitrile) with a gradient of 0−30%
B at 1.0 mL/min for 50 min. The elution was monitored at 214 nm,
and the absorption peaks were fractionated for measuring the calcium-
binding activity. The injection volume was generally 200 μL.
Identification of the Purified Calcium-Binding Peptide. The
molecular mass and amino acid sequence of the purified calcium-
binding peptide were determined using liquid chromatography−
electrospray ionization/mass spectrometry (LC−ESI/MS, Delta Prep
4000, Waters Co., Milford, MA) over the m/z range of 300−3000.
Calcium-Binding Capacity Assay. The calcium-binding capacity
was defined as the content of calcium (μg) bound with peptide (mg)
after the chelating reaction. Lyophilized whey protein hydrolysate was
dissolved in deionized water to be 1.0 mg/mL and mixed with 5 mM
CaCl2 in 0.2 M sodium phosphate buffer (pH 8.0). The solution was
stirred at 37 °C for 2 h, and pH was maintained at 8.0 with a pH
meter. The reaction mixture was centrifuged at 10000g at room
temperature for 10 min to remove insoluble calcium phosphate salts.
Differential Scanning Calorimetry (DSC) Analysis. Thermogravim-
etry (TG)−DSC simultaneous thermal analyzer (STA449C,
NETZSCH, Germany) was employed to measure the thermal
property. Hermetic pans with lyophilized powder samples (5 mg)
were heated from 50 to 600 °C at a programmed heating rate of 10
°C/min in a argon atmosphere. An empty pan was used as a reference.
B
dx.doi.org/10.1021/jf502412f | J. Agric. Food Chem. XXXX, XXX, XXX−XXX